GSK-BRL-029060/329: Acute Phase

Study Sponsor: GSK

Study Title

A Multi-center, Double-blind, Placebo-Controlled Study of Paroxetine and Imipramine in Adolescents with Unipolar Major Depression - Acute Phase

Medicine or Vaccine (generic name)

paroxetine

Sponsor Identification Number

BRL-029060/329: Acute Phase

Trial Registry Identification Number(#'s)

Medical Condition

Depressive Disorder

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=29060/329

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study was conducted in 2 phases - an acute phase and a continuation phase. A comprehensive dataset for the complete study is available. An analysis-ready dataset is not available for this study. An annotated case report form is not available for this study. A blank case report form will be provided. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies.

Date Added to this Site

January 2014